Needham & Company analyst Mike Matson raised the price target on Globus Medical (NYSE: GMED) to $82.00 (from $75.00) while ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE